Lecanemab [1260393-98-3]

TargetMol Chemicals

Lecanemab

10

1260393-98-3

Antibody

Research Use Only

Lecanemab

95%

Lecanemab (BAN-2401) is an IgG1 monoclonal antibody targeting soluble aggregated beta-amyloid (Abeta) with activity against oligomers, protofibrils, and insoluble protofibrils, and may be useful in the study of Alzheimers disease (AD)-induced mild cognitive impairment and mild AD dementia.

3 years

-20°C

12352203